| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both.
|
J Clin Oncol
|
2013
|
2.37
|
|
2
|
Contribution of nicotine acetylcholine receptor polymorphisms to lung cancer risk in a smoking-independent manner in the Japanese.
|
Carcinogenesis
|
2008
|
1.57
|
|
3
|
Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer.
|
Clin Cancer Res
|
2004
|
1.54
|
|
4
|
A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population.
|
Nat Genet
|
2012
|
1.51
|
|
5
|
First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer: a phase II study.
|
J Clin Oncol
|
2006
|
1.49
|
|
6
|
Severe interstitial lung disease associated with amrubicin treatment.
|
J Thorac Oncol
|
2010
|
1.48
|
|
7
|
A review of the benefit-risk profile of gefitinib in Asian patients with advanced non-small-cell lung cancer.
|
Curr Med Res Opin
|
2006
|
1.30
|
|
8
|
Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy.
|
Lung Cancer
|
2008
|
1.27
|
|
9
|
Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
|
Lung Cancer
|
2008
|
1.21
|
|
10
|
Therapeutic priority of the PI3K/AKT/mTOR pathway in small cell lung cancers as revealed by a comprehensive genomic analysis.
|
J Thorac Oncol
|
2014
|
1.19
|
|
11
|
Hypertrophic pulmonary osteoarthropathy as a paraneoplastic manifestation of lung cancer.
|
J Thorac Oncol
|
2010
|
1.15
|
|
12
|
Individuals susceptible to lung adenocarcinoma defined by combined HLA-DQA1 and TERT genotypes.
|
Carcinogenesis
|
2010
|
1.15
|
|
13
|
Expression of breast cancer resistance protein is associated with a poor clinical outcome in patients with small-cell lung cancer.
|
Lung Cancer
|
2008
|
1.14
|
|
14
|
RET fusion gene: translation to personalized lung cancer therapy.
|
Cancer Sci
|
2013
|
1.09
|
|
15
|
Long-term outcomes of 50 cases of limited-resection trial for pulmonary ground-glass opacity nodules.
|
J Thorac Oncol
|
2012
|
1.09
|
|
16
|
Weekly chemotherapy with cisplatin, vincristine, doxorubicin, and etoposide is an effective treatment for advanced thymic carcinoma.
|
Cancer
|
2003
|
1.07
|
|
17
|
Identification and characterization of cancer mutations in Japanese lung adenocarcinoma without sequencing of normal tissue counterparts.
|
PLoS One
|
2013
|
1.05
|
|
18
|
Comparison of pharmacokinetics and pharmacodynamics of docetaxel and Cisplatin in elderly and non-elderly patients: why is toxicity increased in elderly patients?
|
J Clin Oncol
|
2004
|
1.02
|
|
19
|
Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer.
|
J Thorac Oncol
|
2008
|
1.01
|
|
20
|
Regulatory nexus of synthesis and degradation deciphers cellular Nrf2 expression levels.
|
Mol Cell Biol
|
2013
|
1.00
|
|
21
|
Dominant papillary subtype is a significant predictor of the response to gefitinib in adenocarcinoma of the lung.
|
Clin Cancer Res
|
2004
|
0.99
|
|
22
|
Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy.
|
Cancer
|
2008
|
0.97
|
|
23
|
A novel histopathological evaluation method predicting the outcome of non-small cell lung cancer treated by neoadjuvant therapy: the prognostic importance of the area of residual tumor.
|
J Thorac Oncol
|
2010
|
0.97
|
|
24
|
Clinicopathological characteristics of EGFR mutated adenosquamous carcinoma of the lung.
|
Pathol Int
|
2013
|
0.96
|
|
25
|
The lung cancer database project at the National Cancer Center, Japan: study design, corresponding rate and profiles of cohort.
|
Jpn J Clin Oncol
|
2006
|
0.94
|
|
26
|
Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.
|
Cancer Sci
|
2013
|
0.93
|
|
27
|
Morbidity of Myocardial Infarction Multicenter Study in Japan (3M Study): study design and event rates for myocardial infarction and coronary death by age category in Japanese workers.
|
Circ J
|
2005
|
0.93
|
|
28
|
Long-term results of concurrent chemoradiotherapy using cisplatin and vinorelbine for stage III non-small-cell lung cancer.
|
Cancer Sci
|
2012
|
0.92
|
|
29
|
Re-challenge chemotherapy for relapsed non-small-cell lung cancer.
|
Lung Cancer
|
2010
|
0.90
|
|
30
|
Randomized trial of drip infusion versus bolus injection of vinorelbine for the control of local venous toxicity.
|
Lung Cancer
|
2006
|
0.89
|
|
31
|
Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.
|
Lung Cancer
|
2011
|
0.89
|
|
32
|
Eg5 expression is closely correlated with the response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy.
|
Lung Cancer
|
2006
|
0.88
|
|
33
|
Renal toxicity caused by brand-name versus generic cisplatin: a comparative analysis.
|
Jpn J Clin Oncol
|
2013
|
0.88
|
|
34
|
Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma.
|
J Cancer Res Clin Oncol
|
2013
|
0.88
|
|
35
|
Detection of unsuspected distant metastases and/or regional nodes by FDG-PET [corrected] scan in apparent limited-disease small-cell lung cancer.
|
Lung Cancer
|
2007
|
0.88
|
|
36
|
Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer.
|
Chest
|
2010
|
0.87
|
|
37
|
Clinical features of unresectable high-grade lung neuroendocrine carcinoma diagnosed using biopsy specimens.
|
Lung Cancer
|
2011
|
0.86
|
|
38
|
High body mass index correlates with increased risk of venous irritation by vinorelbine infusion.
|
Jpn J Clin Oncol
|
2004
|
0.86
|
|
39
|
Protective effect of magnesium preloading on cisplatin-induced nephrotoxicity: a retrospective study.
|
Jpn J Clin Oncol
|
2014
|
0.86
|
|
40
|
Marital status and non-small cell lung cancer survival: the Lung Cancer Database Project in Japan.
|
Psychooncology
|
2008
|
0.85
|
|
41
|
Associations between blood lipid profiles and risk of myocardial infarction among Japanese male workers: 3M Study.
|
J Atheroscler Thromb
|
2009
|
0.84
|
|
42
|
Breast cancer in first-degree relatives and risk of lung cancer: assessment of the existence of gene sex interactions.
|
Jpn J Clin Oncol
|
2007
|
0.83
|
|
43
|
Identification of prognostic immunophenotypic features in cancer stromal cells of high-grade neuroendocrine carcinomas of the lung.
|
J Cancer Res Clin Oncol
|
2013
|
0.83
|
|
44
|
Serum brain-derived neurotrophic factor and antidepressant-naive major depression after lung cancer diagnosis.
|
Jpn J Clin Oncol
|
2011
|
0.82
|
|
45
|
Antitumor activity of NK012 combined with cisplatin against small cell lung cancer and intestinal mucosal changes in tumor-bearing mouse after treatment.
|
Clin Cancer Res
|
2009
|
0.82
|
|
46
|
Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial).
|
Cancer Chemother Pharmacol
|
2015
|
0.81
|
|
47
|
Aldehyde dehydrogenase 1 expression in cancer cells could have prognostic value for patients with non-small cell lung cancer who are treated with neoadjuvant therapy: identification of prognostic microenvironmental factors after chemoradiation.
|
Pathol Int
|
2013
|
0.81
|
|
48
|
Interstitial shadow on chest CT is associated with the onset of interstitial lung disease caused by chemotherapeutic drugs.
|
Jpn J Clin Oncol
|
2006
|
0.81
|
|
49
|
Phase II study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer.
|
Lung Cancer
|
2002
|
0.81
|
|
50
|
Clinical outcome of small cell lung cancer with pericardial effusion but without distant metastasis.
|
J Thorac Oncol
|
2011
|
0.80
|
|
51
|
Development of Cushing's syndrome during effective chemotherapy for small cell lung cancer.
|
Intern Med
|
2011
|
0.80
|
|
52
|
Susceptibility to lung cancer and genetic polymorphisms in the alcohol metabolite-related enzymes alcohol dehydrogenase 3, aldehyde dehydrogenase 2, and cytochrome P450 2E1 in the Japanese population.
|
Cancer
|
2007
|
0.80
|
|
53
|
Residual powders from Shochu distillation remnants induce apoptosis in human hepatoma cells via the caspase-independent pathway.
|
J Biosci Bioeng
|
2012
|
0.79
|
|
54
|
Remarkable inhibitory effects of hybrid liposomes on growth of human colon cancer cells through induction of cell cycle arrest along with apoptosis.
|
Int J Nanomedicine
|
2011
|
0.79
|
|
55
|
[A resected case of sclerosing thymoma].
|
Nihon Kokyuki Gakkai Zasshi
|
2006
|
0.79
|
|
56
|
Feasibility study of zoledronic acid plus cisplatin-docetaxel as first-line treatment for advanced non-small cell lung cancer with bone metastases.
|
Anticancer Res
|
2012
|
0.79
|
|
57
|
Association of polymorphisms in the MTH1 gene with small cell lung carcinoma risk.
|
Carcinogenesis
|
2006
|
0.79
|
|
58
|
Randomized trial of oral versus intravenous antibiotics in low-risk febrile neutropenic patients with lung cancer.
|
Jpn J Clin Oncol
|
2004
|
0.79
|
|
59
|
Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung.
|
J Cancer Res Clin Oncol
|
2015
|
0.78
|
|
60
|
Prediction of myocardial infarction using coronary risk scores among Japanese male workers: 3M Study.
|
J Atheroscler Thromb
|
2010
|
0.78
|
|
61
|
Trends in chemotherapy for elderly patients with advanced non-small-cell lung cancer.
|
Respir Med
|
2009
|
0.78
|
|
62
|
Comparison of an oxidative stress biomarker "urinary8-hydroxy-2'-deoxyguanosine," between smokers and non-smokers.
|
Biofactors
|
2004
|
0.78
|
|
63
|
Synergistic antitumor activity of the SN-38-incorporating polymeric micelles NK012 with S-1 in a mouse model of non-small cell lung cancer.
|
Int J Cancer
|
2010
|
0.78
|
|
64
|
Clinical outcome of chemoradiation therapy in patients with limited-disease small cell lung cancer with ipsilateral pleural effusion.
|
J Thorac Oncol
|
2008
|
0.77
|
|
65
|
Successful everolimus treatment in a patient with advanced pancreatic neuroendocrine tumor who developed everolimus-induced interstitial lung disease on two occasions: a case report.
|
Chemotherapy
|
2013
|
0.77
|
|
66
|
Second-line docetaxel for patients with platinum-refractory advanced non-small cell lung cancer and interstitial pneumonia.
|
Cancer Chemother Pharmacol
|
2015
|
0.77
|
|
67
|
Selective accumulation of hybrid liposomes into adult T-cell leukemia cells along with induction of apoptosis.
|
Bioorg Med Chem Lett
|
2011
|
0.77
|
|
68
|
Therapeutic effects of hybrid liposomes composed of phosphatidylcholine and docosahexaenoic acid on the hepatic metastasis of colon carcinoma along with apoptosis in vivo.
|
Biol Pharm Bull
|
2011
|
0.77
|
|
69
|
Isolation and identification of sodium 2-propenyl thiosulfate from boiled garlic (Allium sativum) that oxidizes canine erythrocytes.
|
Biosci Biotechnol Biochem
|
2003
|
0.77
|
|
70
|
The antitumor activity of NK012, an SN-38-incorporating micelle, in combination with bevacizumab against lung cancer xenografts.
|
Cancer
|
2010
|
0.77
|
|
71
|
Combination second-line chemotherapy with gemcitabine and docetaxel for recurrent non-small-cell lung cancer after platinum-containing chemotherapy: a phase I/II trial.
|
Cancer Chemother Pharmacol
|
2003
|
0.77
|
|
72
|
Fairly marked enantioselectivity for the hydrolysis of amino acid esters by chemically modified enzymes.
|
J Org Chem
|
2003
|
0.77
|
|
73
|
Safety and efficacy of platinum agents plus etoposide for patients with small cell lung cancer with interstitial lung disease.
|
Anticancer Res
|
2013
|
0.76
|
|
74
|
Effective drug delivery system for duchenne muscular dystrophy using hybrid liposomes including gentamicin along with reduced toxicity.
|
Biol Pharm Bull
|
2011
|
0.76
|
|
75
|
Remarkably high inhibitory effects of docosahexaenoic acid incorporated into hybrid liposomes on the growth of tumor cells along with apoptosis.
|
Int J Pharm
|
2008
|
0.76
|
|
76
|
Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy.
|
J Cancer Res Clin Oncol
|
2014
|
0.76
|
|
77
|
Anticancer effects of residual powder from Barley-Shochu distillation remnants against the orthotopic xenograft mouse models of hepatocellular carcinoma in vivo.
|
Biol Pharm Bull
|
2012
|
0.76
|
|
78
|
[Experimental therapeutic effects of hybrid liposomes on the Alzheimer's disease in vitro].
|
Yakugaku Zasshi
|
2011
|
0.76
|
|
79
|
Three novel single nucleotide polymorphisms in UGT1A10.
|
Drug Metab Pharmacokinet
|
2002
|
0.75
|
|
80
|
Hybrid liposomes inhibit tumor growth and lung metastasis of murine osteosarcoma cells.
|
Cancer Med
|
2013
|
0.75
|
|
81
|
Steric-control for the enantioselective hydrolysis of amino acid esters in hybrid membrane systems.
|
Chem Pharm Bull (Tokyo)
|
2003
|
0.75
|
|
82
|
Membrane targeted chemotherapy with hybrid liposomes for tumor cells leading to apoptosis.
|
Curr Pharm Des
|
2011
|
0.75
|
|
83
|
[Hybrid liposomes as a drug carrier for the oral administration of insulin in diabetic rats].
|
Yakugaku Zasshi
|
2004
|
0.75
|
|
84
|
Comparative evaluation of the Desoxycholate Agar Nissui Food Stamp and swab methods for estimating coliform organisms in poultry processing plants after cleaning in Japan.
|
J Basic Microbiol
|
2004
|
0.75
|
|
85
|
Phase II trial of carboplatin and paclitaxel in non-small cell lung cancer patients previously treated with chemotherapy.
|
Lung Cancer
|
2007
|
0.75
|
|
86
|
Inhibitory effects of extracts from peels of Citrus natsudaidai encapsulated in hybrid liposomes on the growth of tumor cells in vitro.
|
Biol Pharm Bull
|
2004
|
0.75
|
|
87
|
Remarkably enhanced inhibitory effects of three-component hybrid liposomes including sugar surfactants on the growth of lung carcinoma cells.
|
Chem Pharm Bull (Tokyo)
|
2002
|
0.75
|
|
88
|
Cushing's syndrome associated with adenocarcinoma of the lung.
|
Intern Med
|
2003
|
0.75
|
|
89
|
A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non-small-cell lung cancer (NSCLC).
|
Int J Radiat Oncol Biol Phys
|
2005
|
0.75
|
|
90
|
Enzymatic and hyperglycemia stability of chemically modified insulins with hydrophobic acyl groups.
|
Bioorg Med Chem Lett
|
2004
|
0.75
|
|
91
|
[Current Status and Future Perspectives of SCRUM-Japan].
|
Gan To Kagaku Ryoho
|
2017
|
0.75
|
|
92
|
Dose-Escalation Study of Thoracic Radiotherapy in Combination With Pemetrexed Plus Cisplatin in Japanese Patients With Locally Advanced Nonsquamous Non-Small Cell Lung Cancer: A Post Hoc Analysis of Survival and Recurrent Sites.
|
Am J Clin Oncol
|
2016
|
0.75
|
|
93
|
Structure-phototoxicity relationship in Balb/c mice treated with fluoroquinolone derivatives, followed by ultraviolet-A irradiation.
|
Toxicol Lett
|
2005
|
0.75
|
|
94
|
Remarkable immunostimulation effects of hybrid liposomes on human peripheral blood mononuclear cells in vitro.
|
Bioorg Med Chem Lett
|
2006
|
0.75
|
|
95
|
A phase I study of gemcitabine and carboplatin in patients with advanced non-small cell lung cancer and a performance status of 2.
|
Jpn J Clin Oncol
|
2009
|
0.75
|
|
96
|
[A case of well-differentiated nonmucinous adenocarcinoma of the lung with an 18-year clinical course before surgery].
|
Nihon Kokyuki Gakkai Zasshi
|
2003
|
0.75
|